Other biomarkers derive from NGS test: tumor mutation burden (TMB) and the level of expression of interferon-gamma (IFNγ) or INFγ gene expression profile signature (Ayers et al., 2017; Nishino et al., 2017). This evidence concerns the gene IFNG and neoplasm.